the allstate corp. - ALL
ALL
Close Chg Chg %
209.24 -2.84 -1.35%
Closed Market
206.40
-2.84 (1.35%)
Volume: 2.11M
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: the allstate corp. - ALL
ALL Key Data
| Open $208.75 | Day Range 204.80 - 209.36 |
| 52 Week Range 156.66 - 212.85 | Market Cap $55.47B |
| Shares Outstanding 265.03M | Public Float 263.56M |
| Beta 0.46 | Rev. Per Employee N/A |
| P/E Ratio 12.32 | EPS $17.20 |
| Yield 175.84% | Dividend $1.00 |
| EX-DIVIDEND DATE Mar 10, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.11M |
ALL Performance
| 1 Week | 1.37% | ||
| 1 Month | 5.09% | ||
| 3 Months | 7.99% | ||
| 1 Year | 20.97% | ||
| 5 Years | 136.59% |
ALL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
24
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 229.75 | |
| Number of Ratings | 24 | Current Quarters Estimate | 3.654 | |
| FY Report Date | 03 / 2025 | Current Year's Estimate | 17.894 | |
| Last Quarter’s Earnings | 7.67 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 18.32 | Next Fiscal Year Estimate | 21.148 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 18 | 17 | 21 | 20 |
| Mean Estimate | 3.65 | 3.19 | 17.89 | 21.15 |
| High Estimates | 5.74 | 4.41 | 21.48 | 24.70 |
| Low Estimate | 1.76 | 2.30 | 14.95 | 18.79 |
| Coefficient of Variance | 25.03 | 18.30 | 7.76 | 7.21 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 17 | 17 | 15 |
| OVERWEIGHT | 0 | 0 | 1 |
| HOLD | 4 | 4 | 5 |
| UNDERWEIGHT | 1 | 0 | 0 |
| SELL | 2 | 2 | 3 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for The Allstate Corp. - ALL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for The Allstate Corp. - ALL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 27, 2025 | Mark Prindiville | 1,208 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | John Edward Dugenske | 12,055 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | John Edward Dugenske | 3,099 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Jesse E. Merten EVP & Chief Financial Officer | 14,013 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Mario Rizzo | 3,815 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Mario Rizzo | 14,837 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 93,349 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 63,004 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $189.52 per share | 11,940,518.08 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 63,104 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $188.79 per share | 11,913,404.16 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 70,876 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $188.03 per share | 13,326,814.28 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 92,947 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $186.83 per share | 17,365,288.01 |
| Feb 27, 2025 | Mark Prindiville | 4,698 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Christine M. DeBiase EVP, CLO and General Counsel | 8,500 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Suren K. Gupta | 7,934 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Eric K. Ferren SVP, Controller, and CAO | 1,726 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Eric K. Ferren SVP, Controller, and CAO | 665 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Elizabeth A Brady | 1,430 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Christine M. DeBiase EVP, CLO and General Counsel | 2,185 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Suren K. Gupta | 2,040 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Jesse E. Merten EVP & Chief Financial Officer | 3,603 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
The Allstate Corp. in the News
Allstate requests 34% hike on insurance in California as state's insurance crisis escalates: report
Allstate is looking to raise insurance rates for some California customers by 34% as the insurance giant weighs its future in the Golden State.
Allstate to revive Dean Winters' Mayhem character
Allstate is reportedly set to revive Dean Winters' Mayhem character over a year after going silent on the character.